Cargando…
Lung transplantation for patients with severe COVID-19
Lung transplantation can potentially be a life-saving treatment for patients with nonresolving COVID-19–associated respiratory failure. Concerns limiting lung transplantation include recurrence of SARS-CoV-2 infection in the allograft, technical challenges imposed by viral-mediated injury to the nat...
Autores principales: | Bharat, Ankit, Querrey, Melissa, Markov, Nikolay S., Kim, Samuel, Kurihara, Chitaru, Garza-Castillon, Rafael, Manerikar, Adwaiy, Shilatifard, Ali, Tomic, Rade, Politanska, Yuliya, Abdala-Valencia, Hiam, Yeldandi, Anjana V., Lomasney, Jon W., Misharin, Alexander V., Budinger, G. R. Scott |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8050952/ https://www.ncbi.nlm.nih.gov/pubmed/33257409 http://dx.doi.org/10.1126/scitranslmed.abe4282 |
Ejemplares similares
-
Primary graft dysfunction grade correlates with acute kidney injury stage after lung transplantation
por: Toyoda, Takahide, et al.
Publicado: (2023) -
Expression of ACE2—a Key SARS-CoV-2 Entry Factor—Is Not Increased in the Nasal Mucosa of People with Cystic Fibrosis
por: Sala, Marc A., et al.
Publicado: (2022) -
Recipient, donor, and surgical factors leading to primary graft dysfunction after lung transplant
por: Toyoda, Takahide, et al.
Publicado: (2023) -
Early outcomes after lung transplantation for severe COVID-19: a series of the first consecutive cases from four countries
por: Bharat, Ankit, et al.
Publicado: (2021) -
Crosstalk between nonclassical monocytes and alveolar macrophages mediates transplant ischemia-reperfusion injury through classical monocyte recruitment
por: Kurihara, Chitaru, et al.
Publicado: (2021)